Amanote Research
Register
Sign In
4-1bb Ligand (4-1bbl; TNFSF9; CD137L)
Science-Business eXchange
doi 10.1038/scibx.2012.1277
Full Text
Open PDF
Abstract
Available in
full text
Date
December 1, 2012
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Costimulatory Ligand 4-1bbl (CD137L) as an Efficient Adjuvant for Human Antiviral Cytotoxic T Cell Responses
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Serum Concentrations of Soluble 4-1bb and 4-1bb Ligand Correlated With the Disease Severity in Rheumatoid Arthritis
Experimental & Molecular Medicine
A Novel Form of 4-1bbl Has Better Immunomodulatory Activity Than an Agonistic Anti-4-1bb Ab Without Ab-Associated Severe Toxicity
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
4-1bb Signaling Beyond T Cells
Cellular and Molecular Immunology
Infectious Diseases
Medicine
Allergy
Immunology
4-1bb (CD137) Ligand Enhanced Anti-Tumor Immune Response Against Mouse Forestomach Carcinoma in Vivo
Cellular and Molecular Immunology
Infectious Diseases
Medicine
Allergy
Immunology
CD137 (4-1bb) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Recombinant Salmonella-Based 4-1bbl Vaccine Enhances T Cell Immunity and Inhibits the Development of Colorectal Cancer in Rats: In Vivo Effects of Vaccine Containing 4-1bbl
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Soluble CD137 (4-1bb) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients With Hematological Malignancies
Journal of Immunology
Allergy
Immunology
Enhanced CD4 T Cell Responsiveness in the Absence of 4-1bb
Journal of Immunology
Allergy
Immunology
